Impact of a Guideline Dissemination Strategy on Provincial Blood Glucose Test Strip Prescription Rates: An Interrupted Time Series Analysis

2017 ◽  
Vol 41 (5) ◽  
pp. S77
Author(s):  
Jennica Nichols ◽  
Tara Gomes ◽  
Baiju Shah ◽  
Muhammad Mamdani ◽  
Carolyn Gall Casey ◽  
...  
Keyword(s):  
Time Series ◽  
Blood Glucose ◽  
Interrupted Time Series ◽  
Test Strip ◽  
Interrupted Time Series Analysis ◽  
Dissemination Strategy ◽  
Blood Glucose Test ◽  
Guideline Dissemination ◽  
Prescription Rates ◽  
Glucose Test

scholarly journals Changes in mammography screening in Ontario and Alberta following national guideline dissemination: an interrupted time series analysis

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 1044
Author(s):  
Christine Fahim ◽  
Natasha Wiebe ◽  
Rosane Nisenbaum ◽  
Jemila S. Hamid ◽  
Joycelyne E. Ewusie ◽  
...  
Keyword(s):  
Time Series ◽  
Time Series Analysis ◽  
Interrupted Time Series ◽  
National Guideline ◽  
Income Quintile ◽  
Interrupted Time Series Analysis ◽  
Dissemination Strategy ◽  
Series Analysis ◽  
Guideline Dissemination ◽  
Mammography Use

Background: In November 2011, the Canadian Task Force on Preventive Health Care released guidelines for screening women at average breast cancer risk. Weak recommendations (framed using GRADE methodology) were made for screening women aged 50 to 74 years every two to three years, and for not screening women aged 40 to 49 years. Methods: We conducted an interrupted time series analysis using administrative data to examine bilateral mammography use before and after a national guideline dissemination strategy targeting primary care physicians. Women aged 40 to 74 years living in Ontario or Alberta from 30th November 2008 to 30th November 2014 were included. Strata included age, region of residence, neighbourhood income quintile, immigration status, and education level. Results: In both provinces, mammography use rates were lower in the post-intervention period (527 vs. 556 and 428 vs. 465/1000 participant-months - the monthly screening rate/1000 - in Ontario and Alberta, respectively). In Ontario, mammography trends decreased following guideline release to align with recommendations for women aged 40 to 74 (decrease of 2.21/1000 women, SE 0.26/1000, p<0.0001). In Alberta, mammography trends decreased for women aged 40 to 49 years (3/1000 women, SE 0.32, p<0.001) and 50 to 69 (2.9/1000 women, SE 0.79, p<0.001), but did not change for women aged 70 to 74 (0.7/1000 women, SE 1.23, p=0.553). In both provinces, trends in mammography use rates were sustained for up to three years after guideline release. Conclusions: The guideline dissemination strategy appeared to increase uptake of guideline-concordant screening practice in women aged 40 to 49 years in Ontario and Alberta and for women aged 50 to 74 years in Ontario. Further work is required to understand these findings and whether shared decision making about mammography between women and providers increased among women considering mammography.

Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada

2018 ◽  
Vol 42 (1) ◽  
pp. 5-10 ◽  
Author(s):  
Lynette Kosar ◽  
Wasem Alsabbagh ◽  
Xinya Lu ◽  
Lisa M. Lix ◽  
Yvonne Shevchuk ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Test Strip ◽  
Blood Glucose Test ◽  
Glucose Test

scholarly journals MON-181 Evaluation of the GLUCOCARD Shine Connex Bluetooth Enabled Blood Glucose Monitoring System's Ease of Use

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Julie Walker ◽  
Taylor Thompson ◽  
Patricia Gill ◽  
Raji Shankar
Keyword(s):  
Blood Glucose ◽  
Glucose Monitoring ◽  
Test Strip ◽  
Ease Of Use ◽  
Blood Glucose Monitoring ◽  
Self Management ◽  
Blood Glucose Test ◽  
Consumer Study ◽  
Glucose Test ◽  
Self Test

Abstract Background: It is important that a Blood Glucose Monitoring System (BGMS) is easy to use since it is a critical tool used in the self-management of diabetes, including the prevention of micro and macrovascular complications. The “Ease of Use” consumer study is typically evaluated as part of the FDA 510(k) approval process for BGMS. Purpose: The objective of this study was to further verify the Ease of Use of the GLUCOCARD Shine Connex Bluetooth Enabled BGMS. Methods: A total of 20 subjects with confirmed diabetes between the ages of 40 to 89 participated in the IRB-approved study at ARKRAY in Minneapolis, MN during October 2018. 80.0% of the subjects fell between the ages of 60 to 89 years of age. The subjects were asked to perform a fingerstick self-test and answer a questionnaire directed at the Ease of Use of the device and test strip. All the subjects responded to the topics in the questionnaire which included, “Removing a Test Strip from Bottle”, “Inserting a Test Strip into the Meter”, “Removing a Test Strip from the Meter”, “Performing a Blood Glucose Test from your Fingertip” and “Reading Meter Display”. The subjects were asked to rate the topics as Very Easy, Easy, OK, Difficult, or Very Difficult. For evaluation purposes, these topics were grouped as Positive [Very Easy/Easy/OK] and Negative [Difficult/Very Difficult]. Results: From the questionnaire, “Removing a Test Strip from Bottle” and “Inserting a Test Strip into the Meter” received a 95.0% positive rating while all the remaining topics received a 100.0% positive rating, including “Removing a Test Strip from the Meter”, “Performing a Blood Glucose Test from your Fingertip” and “Reading Meter Display”. Conclusion: The GLUCOCARD Shine Connex Bluetooth Enabled BGMS scored a 98.0% positive overall average Ease of Use rating by the subjects.

Sign in / Sign up

Export Citation Format

Share Document